发明名称 Topical formulation
摘要 <p>A topical formulation comprising: (a) an NSAID or a pharmaceutically acceptable salt thereof; (b) a polyhydric alcohol; (c) a C10—C14straight chain fatty acid or derivative thereof; (d) a C2- C4alcohol; (e) a gelling agent selected from the group consisting of non-ionic polymers; (f) optionally additional pharmaceutically acceptable excipients; (g) water up to 100%. The NSAID is selected from ibuprofen, ketoprofen, flurbiprofen, diclofenac, or naproxen, and is preferably ibuprofen. The polyhydric alcohol is preferably propylene glycol or butylene glycol. The fatty acid is preferably lauric acid or myristic acid. The C2—C4alcohol is preferably isopropanol. The gelling agent is preferably hydroxypropyl cellulose, hydroxylethyl cellulose, or a polyacrylamide. The topical formulation may further comprise an ingredient that stimulates cold or warm receptors in the skin, preferably menthol or capsaicin. The formulation may comprise up to 10% menthol. The topic formulations may further comprise an additional analgesic agent.</p>
申请公布号 GB201020601(D0) 申请公布日期 2011.01.19
申请号 GB20100020601 申请日期 2010.12.06
申请人 RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED 发明人
分类号 主分类号
代理机构 代理人
主权项
地址